These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27399979)

  • 21. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
    Soysal A; Toprak D; Koc M; Arikan H; Akoglu E; Bakir M
    Nephrol Dial Transplant; 2012 Apr; 27(4):1645-50. PubMed ID: 21931124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
    Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
    Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation.
    Zenner D; Loutet MG; Harris R; Wilson S; Ormerod LP
    Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High incidence of latent tuberculous infection among South African health workers: an urgent call for action.
    McCarthy KM; Scott LE; Gous N; Tellie M; Venter WD; Stevens WS; Van Rie A
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):647-53. PubMed ID: 25946353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay.
    Jong Lee K; Ae Kang Y; Mi Kim Y; Cho SN; Wook Moon J; Suk Park M; Kyu Kim S; Chang J; Sam Kim Y
    Scand J Infect Dis; 2010 Sep; 42(9):672-8. PubMed ID: 20482459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
    Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
    BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis.
    Pontarelli A; Marchese V; Scolari C; Capone S; El-Hamad I; Donato F; Moioli R; Girardi E; Cirillo DM; Castelli F; Matteelli A
    Travel Med Infect Dis; 2019; 27():39-45. PubMed ID: 30347248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area.
    Loutet MG; Burman M; Jayasekera N; Trathen D; Dart S; Kunst H; Zenner D
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of latent tuberculosis infection rate between contacts with active tuberculosis and non-contacts.
    Yoo JW; Jo KW; Park GY; Shim TS
    Respir Med; 2016 Feb; 111():77-83. PubMed ID: 26725461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study.
    Ronald LA; Campbell JR; Rose C; Balshaw R; Romanowski K; Roth DZ; Marra F; Schwartzman K; Cook VJ; Johnston JC
    Clin Infect Dis; 2019 Nov; 69(12):2101-2108. PubMed ID: 30856258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.
    Hadaya K; Bridevaux PO; Roux-Lombard P; Delort A; Saudan P; Martin PY; Janssens JP
    Transplantation; 2013 Jun; 95(12):1485-90. PubMed ID: 23694948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of latent tuberculosis infection and its risk factors in schoolchildren and adolescents in Shanghai, China.
    Hu Y; Zhao Q; Wu L; Wang W; Yuan Z; Xu B
    Eur J Public Health; 2013 Dec; 23(6):1064-9. PubMed ID: 23867560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the TBAg/PHA ratio in the T-SPOT(®).TB assay to distinguish TB disease from LTBI in an endemic area.
    Wang F; Hou HY; Wu SJ; Zhu Q; Huang M; Yin B; Huang J; Pan YY; Mao L; Sun ZY
    Int J Tuberc Lung Dis; 2016 Apr; 20(4):487-93. PubMed ID: 26970158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia.
    El-Helaly M; Khan W; El-Saed A; Balkhy HH
    J Infect Public Health; 2014; 7(6):481-8. PubMed ID: 25194817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis.
    Campbell JR; Johnston JC; Ronald LA; Sadatsafavi M; Balshaw RF; Cook VJ; Levin A; Marra F
    Am J Kidney Dis; 2019 Jan; 73(1):39-50. PubMed ID: 30269868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis screening using IGRA and chest computed tomography in patients with inflammatory bowel disease: A retrospective study.
    Song DJ; Tong JL; Peng JC; Cai CW; Xu XT; Zhu MM; Ran ZH; Zheng Q
    J Dig Dis; 2017 Jan; 18(1):23-30. PubMed ID: 28009090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.
    Wingate LT; Coleman MS; de la Motte Hurst C; Semple M; Zhou W; Cetron MS; Painter JA
    BMC Public Health; 2015 Dec; 15():1201. PubMed ID: 26627449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.